Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NEXT VENTŪRES is an early-stage venture capital firm founded in 2019 and based in the United States. The firm is dedicated to addressing the root causes of poor and disparate health outcomes through innovative whole-person care solutions. With a focus on enhancing human capability, NEXT VENTŪRES aims to optimize and integrate care across the health continuum. The firm has successfully built a portfolio of 11 companies, showcasing its commitment to investing in transformative healthcare technologies. The leadership team includes notable figures such as Lance Armstrong and Melanie Strong, who bring a wealth of experience and insight into the healthcare sector. NEXT VENTŪRES is recognized for its proactive approach to healthcare investment, emphasizing the importance of interconnected care solutions that span various sectors, including healthcare, AI, biotech, and consumer health. The firm’s reputation is built on its strategic investments that not only promise financial returns but also contribute to meaningful advancements in health and wellness.
NEXT VENTŪRES specializes in investing in innovative healthcare access solutions that enhance human capability. The firm’s investment focus includes sectors such as healthcare, artificial intelligence, biotechnology, and consumer health. They are particularly interested in companies that aim to optimize and integrate care across the health continuum, believing that proactive and interconnected care is essential for improving health outcomes. The firm invests at the pre-seed, seed, and seed-plus stages, allowing them to support startups from their inception through early growth phases. NEXT VENTŪRES seeks to partner with founders who are passionate about creating solutions that address significant health challenges. Their areas of interest include health, wellness, and sports technology, with a keen eye on innovative applications of AI in healthcare. By focusing on these sectors, NEXT VENTŪRES aims to drive advancements that not only improve access to care but also enhance the overall quality of health services.
NEXT VENTŪRES has built a diverse portfolio of 11 companies, each contributing to the firm's mission of enhancing healthcare access and outcomes. Notable investments include **Pair Team**, an AI-powered care delivery system designed for the safety net, and **Oura Ring**, a smart ring that tracks fitness, stress, sleep, and overall health. Other significant portfolio companies include **BranchLab**, which focuses on AI-native platforms for pharmaceutical commercialization, and **Cofertility**, a human-centered egg donation platform that connects donors with intended parents. The firm also backs **Trial Library**, an AI platform that accelerates access to precision medicine, and **Vital Biosciences**, which aims to reimagine lab testing for accessible care. Additionally, **SteadyMD** provides high-quality telehealth experiences at scale, while **Mood Health** focuses on making mental health care affordable and accessible. Other investments include **Juno Medical**, which offers modern healthcare for families, **Prose Foods**, innovating in food sourcing and production, and **Genopets**, a
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.